{"pageContent": "Purpose: Health-related quality-of-life (HRQOL) concerns are pivotal in choosing prostate cancer therapy. However, concurrent HRQOL comparison between brachytherapy, external radiation, radical prostatectomy, and controls is hitherto lacking. HRQOL effects of hormonal adjuvants and of cancer control after therapy also lack prior characterization.", "metaData": {"source": "Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/17578466/"}}